Sabina Ramirez Hincapie

• Toxicology, the study of the adverse effects of chemicals and physical agents on living organisms, is a critical process in chemical and drug development. The low throughput, high costs, limited predictivity and ethical concerns related to traditional animal-based toxicity studies render them impractical to assess the growing number and complexity of both existing and new compounds and their formulations. These factors together with the increasing implementation of more demanding regulations, evidence the current need to develop innovative, reliable, cost effective and high throughput toxicological methods. The use of metabolomics in vitro presents the powerful combination of a human relevant system with a multiparametric approach that allows assessing multiple endpoints in a single biological sample. Applying metabolomics in a cell-based system offers an alternative to both, the ethical concerns and relevance of animal testing and the restraining nature of single endpoint evaluations characteristic of conventional toxicological in vitro assays. However, there are still challenges that hamper the expansion of metabolomics beyond a research tool to a feasible and implementable technology for toxicology assessment. The aim of this dissertation is to advance the applications of in vitro metabolomics in toxicology by addressing three major challenges that have limited its widespread implementation in the field. In chapter 2 the restrictive high cost and low throughput of in vitro metabolomics was addressed through the development, standardization and proof of concept of a high throughput targeted LC-MS/MS in vitro metabolomics platform for the characterization of hepatotoxicity. In chapter 3, the use of the developed in vitro metabolomics system was expanded beyond hazard identification, to its implementation for deriving dose- and time response metrics that were shown useful for Point of departure (PoD) estimations for human risk assessment. Finally, in chapter 4 in order to increase the reliance and confidence of using in vitro metabolomics data for risk assessment, the human relevance of the metabolomics in vitro assays was attempted to be improved by the implementation and evaluation of in vitro metabolomics in a hiPSCs-derived 3D liver organoid system. The work developed here demonstrates the suitable of in vitro metabolomics for mechanistic-based hazard identification and risk assessment. By advancing the applications of metabolomics in toxicology, this work has significantly contributed to the aim of toxicology of the 21st century for a human-relevant non-animal toxicological testing, supporting the toxicology task of protecting human health and the environment.